Commentary – Pharmaceutical Technology: “Cannabinoids receptors: popular preclinical target but banned in 137 countries”

Cannabinoid receptors are currently the most popular targets for CNS in preclinical development, with 391 drugs tagged in total. Cannabinoid receptors are a popular therapeutic target for cannabinoid-based drugs in the treatment of pain, neurological disorders and inflammation, according to GlobalData’s Pharma Intelligence Centre Drugs database. In 2022, a surge in the pipeline has led […]